Advanced prostate cancer experimental radioactive treatment—clinical trial decision making: patient experiences

Decision-making in Prostate Cancer Treatment

Today, most men who have localized prostate cancer at diagnosis and who undergo either active surveillance or curative treatment can expect to have a disease-specific survival of at least 10 years2–4. Even men with metastatic disease can expect increased survival as new therapeutic agents become available and alternative regimes for existing treatments are tried5,6. Those facts, combined with a...

Shared Decision Making Supported by Patient Decision Aids for Prostate Cancer Screening and Treatment

El cáncer de próstata es un problema importante para los hombres mayores en países desarrollados. Las decisiones acerca del screening y tratamiento del cáncer de próstata se caracterizan por múltiples opciones razonables que parecen “arriesgadas”, donde las preferencias personales de los pacientes son importantes. Se va reconociendo de modo creciente la toma de decisión compartida entre el paci...

Prostate cancer survivors' beliefs about screening and treatment decision-making experiences in an era of controversy.

OBJECTIVE Controversy about the costs and benefits of screening and treatment of prostate cancer (PCa) has recently intensified. However, the impact of the debate on PCa patients has not been systematically studied. METHODS We assessed knowledge of, and attitudes toward, the U.S. Preventive Services Task Force's (USPSTF) May 2012 recommendation against PSA-based screening among men diagnosed ...

Ethics and Decision Making for Radioactive Waste

A randomized controlled trial of shared decision making for prostate cancer screening.

OBJECTIVE To evaluate a patient-educational approach to shared decision making for prostate cancer screening. DESIGN Randomized controlled trial with preoffice visit assessment and 2-week follow-up. SETTING University-based family practice center. PATIENTS Men aged 45 through 70 years with no history of prostate cancer or treatment for prostate disease (N = 160). Two patients were unavail...